Skip to main content
Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia.
Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study.
Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium.
Genetic variants associated with white blood cell count amongst individuals with sickle cell disease.
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia.
Time to rethink haemoglobin threshold guidelines in sickle cell disease.
A complication risk score to evaluate clinical severity of thalassaemia syndromes.